Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Comprehensive immunophenotyping of gastric adenocarcinoma identifies an inflamed class of tumors amenable to immunotherapies

ABSTRACT: Comprehensive immunophenotyping of gastric adenocarcinoma identifies an inflamed class of tumors amenable to immunotherapies

PROVIDER: PRJNA1095884 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Comprehensive immunophenotyping of gastric adenocarcinoma identifies an inflamed class of tumors amenable to immunotherapies

Project description:RNA from 56 gastric adenocarcinoma was analyzed on the nCounter system using the PanCancer IO 360, a curated panel including 770 genes across key immuno-oncology pathways and processes

2025-03-23 | GSE263115 | GEO

RNA-seq of biopsies, crypts and organoids of inflamed and non-inflamed biopsies of ulcerative colitis patients

Project description:Patient-derived intestinal organoids provide an excellent tool to unravel mechanisms underlying ulcerative colitis (UC). Fresh biopsies, to isolate crypts and culture organoids, were obtained from both inflamed and non-inflamed regions from eight patients with active UC (Mayo endoscopic subscore ≥2), and from eight non-IBD controls.To address the inflammatory character of ex vivo organoids, we compared the transcriptome of biopsies, crypts and organoids derived from inflamed, and non-inflamed regions and aimed to (re-)induce inflammation ex vivo.

2020-10-08 | E-MTAB-7860 | biostudies-arrayexpress

RNA-seq for inflamed and non-inflamed mucosa in patients with Crohn's disease

Project description:To investigate the gene expression profile of inflamed and non-inflamed mucosa in patients with Crohn's disease. To investigate TCR repertoires in the intestinal mucosa, the expression profile of the TCR repertoire gene was analyzed.

2022-07-19 | GSE208303 | GEO

Immunophenotyping peripheral blood mononuclear cells in human HFpEF

Project description:Immunophenotyping peripheral blood mononuclear cells in human HFpEF

| PRJNA926645 | ENA

RNA-seq for inflamed and non-inflamed mucosa in patients with Crohn's disease

Project description:RNA-seq for inflamed and non-inflamed mucosa in patients with Crohn's disease

| PRJNA859159 | ENA

Class I Typing

Project description:Class I Typing

| PRJEB33618 | ENA

Immunophenotyping and transcriptional profiling of human plasmablasts in dengue.

Project description:Immunophenotyping and transcriptional profiling of human plasmablasts in dengue.

| PRJNA719802 | ENA

Single cell immunophenotyping of the Lyme erythema migrans lesion

Project description:Single cell immunophenotyping of the Lyme erythema migrans lesion

| PRJNA1263516 | ENA

Genomic analysis to identify correlates of the inflamed tumor phenotype in patients with advanced malignancies receiving immunotherapy

Project description:This biomarker study will analyze tissues from patients with cancer who are receiving immunomodulatory treatment (or therapy that could be hypothesized to modulate the immune response), to correlate molecular/genetic features of the tumor cells, the host, and the intestinal microbiome with the immunologic phenotype of the tumor microenvironment. Recent data have suggested that patients with pre-existing T cell infiltration in the tumor microenvironment and/or an “inflamed” gene expression profile in tumor sites have better clinical outcome following treatment with several immunotherapeutic approaches. However, the mechanism by which this spontaneous anti-tumor immune response develops in only a subset of patients is not understood. Potential correlations between mutational patterns in the tumor, germline genetic polymorphisms, peripheral blood immune response parameters, and the composition of intestinal microbiota and the presence or absence of a T cell-infiltrated tumor microenvironment will be sought. Understanding these mechanisms will have important implications for future patient selection for treatment with immunotherapies and highlight new potential pathways for therapeutic development. Mechanisms of secondary resistance to immunotherapies also will be interrogated using tissues obtained at time of recurrence.

2025-09-09 | GSE285619 | GEO

Discovery of BMS-986408, a First-In-Class Dual DGK⍺ and DGK훇 Inhibitor That Unleashes PD-1 Checkpoint and CAR-T Cell Immunotherapies

Project description:Discovery of BMS-986408, a First-In-Class Dual DGK⍺ and DGK훇 Inhibitor That Unleashes PD-1 Checkpoint and CAR-T Cell Immunotherapies

| PRJNA1243949 | ENA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data